| An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening GB Lazenby, PT Taylor, BS Badman, E Mchaki, JE Korte, DE Soper, ... Clinical therapeutics 36 (1), 38-45, 2014 | 138 | 2014 |
| Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action KB Cartmell, J Young-Pierce, S McGue, AJ Alberg, JS Luque, ... Papillomavirus Research 5, 21-31, 2018 | 104 | 2018 |
| HPV vaccination communication messages, messengers, and messaging strategies KB Cartmell, CR Mzik, BL Sundstrom, JS Luque, A White, J Young-Pierce Journal of Cancer Education 34, 1014-1023, 2019 | 59 | 2019 |
| Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells MW Ali, E Cacan, Y Liu, JY Pierce, WT Creasman, MM Murph, ... PloS one 8 (3), e60185, 2013 | 59 | 2013 |
| HPV and HPV vaccination knowledge and attitudes among medical students in Alabama CL Daniel, L McLendon, CL Green, KJ Anderson, JY Pierce, A Perkins, ... Journal of Cancer Education 36, 168-177, 2021 | 58 | 2021 |
| Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines TR Buchanan, WS Graybill, JY Pierce Human Vaccines & Immunotherapeutics 12 (6), 1352-1356, 2016 | 54 | 2016 |
| Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign B Sundstrom, KB Cartmell, AA White, H Well, JY Pierce, HM Brandt Vaccines 9 (4), 352, 2021 | 48 | 2021 |
| A reproductive justice approach to understanding women's experiences with HPV and cervical cancer prevention B Sundstrom, E Smith, C Delay, JS Luque, C Davila, B Feder, V Paddock, ... Social Science & Medicine 232, 289-297, 2019 | 47 | 2019 |
| Protecting the next generation: Elaborating the health belief model to increase HPV vaccination among college-age women B Sundstrom, LA Carr, AL DeMaria, JE Korte, SC Modesitt, JY Pierce Social Marketing Quarterly 21 (3), 173-188, 2015 | 45 | 2015 |
| It’s my time: applying the health belief model to prevent cervical cancer among college-age women B Sundstrom, HM Brandt, L Gray, J Young Pierce Journal of Communication Management 22 (2), 161-178, 2018 | 38 | 2018 |
| Factors associated with HPV vaccination initiation among United States college students L McLendon, J Puckett, C Green, J James, KJ Head, H Yun Lee, ... Human Vaccines & Immunotherapeutics 17 (4), 1033-1043, 2021 | 36 | 2021 |
| Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia RD Cuff, T Buchanan, E Pelkofski, J Korte, SP Modesitt, JY Pierce American journal of obstetrics and gynecology 214 (6), 752. e1-752. e6, 2016 | 36 | 2016 |
| Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings GB Rocque, DAN Dent, SA Ingram, NE Caston, HB Thigpen, FR Lalor, ... JCO Oncology Practice 18 (12), e1943-e1952, 2022 | 35 | 2022 |
| Increasing HPV vaccination through policy for public health benefit HM Brandt, JY Pierce, A Crary Human vaccines & immunotherapeutics 12 (6), 1623-1625, 2016 | 35 | 2016 |
| Health care‐related time costs in patients with metastatic breast cancer GB Rocque, CP Williams, SA Ingram, A Azuero, ST Mennemeyer, ... Cancer Medicine 9 (22), 8423-8431, 2020 | 32 | 2020 |
| Suppression of GNAI2 message in ovarian cancer JR Raymond, KM Appleton, JY Pierce, YK Peterson Journal of ovarian research 7, 1-10, 2014 | 32 | 2014 |
| Recommendations for a national agenda to substantially reduce cervical cancer JS Smith, NT Brewer, D Saslow, K Alexander, MR Chernofsky, R Crosby, ... Cancer Causes & Control 24, 1583-1593, 2013 | 31 | 2013 |
| Health insurance literacy and financial hardship in women living with metastatic breast cancer CP Williams, M Pisu, A Azuero, KM Kenzik, RD Nipp, MS Aswani, ... JCO Oncology Practice 16 (6), e529-e537, 2020 | 27 | 2020 |
| Lymphovascular space invasion in uterine corpus cancer: what is its prognostic significance in the absence of lymph node metastases? SA Neal, WS Graybill, E Garrett-Mayer, ML McDowell, VE McLean, ... Gynecologic Oncology 142 (2), 278-282, 2016 | 27 | 2016 |
| Minority participation in phase 1 gynecologic oncology clinical trials: three decades of inequity E Awad, R Paladugu, N Jones, JY Pierce, J Scalici, CA Hamilton, ... Gynecologic Oncology 157 (3), 729-732, 2020 | 26 | 2020 |
